TVTatiana L. Vershinina

Tatiana L. Vershinina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tatiana L. Vershinina has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Potential and prospects for using biomedical resource collections obtained from pediatric patients for clinics and research

    by О. В. Мельник, A. M. Zlotina, S. G. Fetisova, Yu. V. Fomicheva, П. С. Сокольникова, A. A. Kolesov, T. L. Vershinina, E. S. Vasichkina, A. A. Kostareva, A. O. Konradi

    Aim . To demonstrate the development and potential applications of bio­medical resource collections of pediatric patient biomaterials, as well as the potential for their differentiated use for clinical and research pur­poses in a multidisciplinary hospital setting at a federal research center. Material and methods . The study included biomaterial from pediatric pa­tients and their first-­degree relatives, banked between 2016 and 2025 as part of research projects at the Almazov National Medical Re­search Center in the field of clinical genetics and pediatrics. De­oxy­ri­bo­nucleic acid (DNA) isolated from whole blood samples and dried blood spots was used for genetic testing using modern molecular genetic dia­gnos­tic methods. Results . The potential of using bioresource collections of pediatric pa­tient biomaterial was demonstrated using familial cases of rare mo­no­genic diseases, for which previously collected biomaterial from the biobank was used to establish a diagnosis and determine follow-up strategies for family members, identify risks to future offspring, and re­ceive advance data on the management of patients with spe­ci­fic he­re­ditary syndromes. Additionally, the ability to predict new phe­no­ty­pes associated with a known gene, and conversely, to uncover the rela­tion­ship of new genes with a known phenotype, was demonstrated using examp­les of familial diseases, where biobank biomaterial enabled seg­re­gation analysis. Using biomaterial from cohorts of patients with a specific pathology, the potential for developing novel diagnostic al­go­rithms and laboratory test systems, a differentiated approach to se­lec­ting a targeted genetic panel for diagnosis, and the identification of new clinical and genetic disease features was showed. A founder mu­ta­tion was showed to be identified in a pathology determined in a spe­cific ethnic group, with the potential to describe the onset time and geo­graphic distribution. Conclusion . The creation of bioresource collections obtained from pediatric populations is a complex, yet extremely important, clini­cal­ly necessary, and promising scientific task. Its implementation faci­li­tates translational research aimed at improving diagnostic methods, under­stan­ding the pathogenesis and progression of childhood diseases, and the influence of environmental factors on their development. It also faci­litates the search for new genetic causes of hereditary pathologies and the description of new phenotypes associated with known genes. It also identifies predictors of disease severity and prognosis. In the long term, it facilitates the search for novel therapeutic approaches and under­stan­ding the disease pathogenesis in adults.

  • Open Access

    Cardiovascular toxicity of antiGD2-specific monoclonal antibodies in a patient with osteosarcoma. A clinical case report

    by Alika A. Kulyova, Svetlana A. Kulyova, Rina I. Khabarova, Evgeniy M. Senchurov, Elena A. Mikhailova, Ksenia M. Borokshinova, Valeria S. Ignatova, Elizaveta A. Prosekina, Tatiana L. Vershinina

    Immunotherapy is one of the most effective methods of cancer therapy. There are five main groups of immunotherapy, including treatment with chimeric antigen receptor T cells, checkpoint inhibitors, anticancer vaccines, antibody-based targeted therapies, and oncolytic viruses. On the adult cohort of patients, immunotherapy has been proven to increase the survival rate of patients with cancer. At the same time, in some patients, it can cause an immune-mediated damage and contribute to unfavorable heart immune modulation and heart failure. Immunotherapy can target many components of the cardiovascular system, including the myocardium, blood vessels, electrical wiring, and the pericardium. Activated T lymphocytes (CD4 + and CD8 + T cells) penetrate the heart tissue and skeletal targets, which leads to local inflammation and damage. Additional theoretical mechanisms for side effects include autoantibody recognition of self-antigens and T cell-mediated damage to cardiomyocytes and stressed endothelial cells. After treatment with T cells, the level of proinflammatory cytokines may increase, which is often the cause of cytokine release syndrome, the occurrence of which is considered a “targeted, non-neoplastic” effect. Proinflammatory cytokines can have negative cytotoxic effects on cardiomyocytes, resulting in reduced myocardial contractility, cardiomyopathy, and hypotension. This review presents a clinical case of cardiotoxicity due to the use of antiGD2 monoclonal antibodies in a child with a refractory form of osteosarcoma.

  • Open Access

    Multisystem involvement and early onset of Danon’s disease in female children. Clinical cases

    by S. G. Fetisova, D. Yu. Alekseeva, A. N. Abdullaev, T. L. Vershinina, A. V. Ryzhkov, M. S. Baev, A. A. Kostareva, T. M. Pervunina, E. S. Vasichkina

    Danon’s disease (DD) is a rare multisystem disease caused by pathogenic variants in the LAMP2 gene. Men are characterized by a multisystemic Involvement, most often represented by a triad of symptoms: skeletal myopathy, cardiomyopathy (hypertrophic phenotype), and cognitive dysfunction. Women are more likely to have isolated heart disease. Given that women are less likely to have extracardiac manifestations, the diagnosis of the disease in females can be very difficult and untimely. In this article, we present 2 clinical cases of BD in adolescent girls, characterized by an early onset of the disease and a multisystem course.

  • Open Access

    Physical performance and physical activity of children with corrected congenital heart defects

    by S. A. Pomeshkina, A. V. Berezina, T. L. Vershinina, E. V. Yakovleva, E. S. Vasichkina, T. M. Pervunina, E. A. Demchenko

    Background: despite the great contribution of physical activity (PA) to the health of children after correction of congenital heart defects (CHD), in the literature there are only isolated data on PA and the performance of children after correction of congenital heart defects. Objective: to assess physical activity and physical performance in children after radical intervention for congenital heart disease. Material and methods. The study included 32 children after radical correction of congenital heart disease. In addition to standard research methods, all patients underwent a cardiopulmonary stress test (CPST), as well as a structured interview on physical activity. Results. According to the survey, 81 % of children did not achieve the recommended 60 minutes of daily PA. Only 44 % of children attended sports clubs or sections. The amount of sedentary time in children was 8.4 hours a day, while the duration of entertainment “screen time” was 3 hours. A separate analysis of physical performance was carried out in subgroups formed depending on physical training (PT) activities. In children who regularly engaged in PT, the threshold load power and heart rate at the height of physical activity were higher compared to children who did not engage in PT. In addition, they had higher VO2peak and lower ventilator CO2 equivalent (VE/VCO2). Conclusion. Children with corrected congenital heart disease, without contraindications to physical education and sports, mostly lead a sedentary lifestyle and have insufficient physical activity and performance. However, regular physical training after radical correction of congenital heart disease significantly increases the performance of children due to an adequate increase in cardiac output and minute ventilation during physical activity.


  • Open Access

    Clinical characteristics of the “hot phase” of arrhythmogenic cardiomyopathy in a pediatric patient

    by O. A. Kofeynikova, D. Yu. Alekseeva, S. G. Fetisova, E. V. Yakovleva, O. L. Peregudina, T. L. Vershinina, A. A. Kostareva, E. S. Vasichkina

    This article describes a rare clinical manifestation of arrhythmogenic cardiomyopathy in a 13-year-old boy - the “hot phase”, characterized by severe chest pain and a significant increase on a level of troponin I. The clinical case demonstrates the difficulties of the differential diagnosis of this disease and an importance of an integrated approach to examination of the patient, including cardiac magnetic resonance imaging and genetic testing.


  • Open Access

    Left ventricular noncompaction associated with titin-truncating variants in the TTN gene

    by Yu. A. Vakhrushev, T. I. Vershinina, P. A. Fedotov, A. A. Kozyreva, A. M. Kiselev, Yu. V. Fomicheva, E. S. Vasichkina, T. M. Pervunina, A. A. Kostareva, Ю. А Вахрушев

    Aim. To study the association of genetic variants in the titin gene ( TTN ) with the development and clinical course of left ventricular noncompaction in different age groups. Material and methods. The article discusses three clinical cases of patients with left ventricular noncompaction who were treated at theAlmazovNationalMedicalResearchCenter. We performed a new-generation sequencing of 108 genes associated with cardiomyopathies, as well as whole exome sequencing and Sanger sequencing. Results. We identified genetic variants in the TTN gene leading to the synthesis of truncated protein: in the first two cases, the cause of noncompaction was a thirteen nucleotide deletion with a reading frame shift, in the second, a nonsense mutation. An algorithm for assessing the pathogenicity of the identified variants and a scheme of diagnostic genetic search are presented. Conclusion. Causal role of TTN -truncating variants in development of cardiomyopathies and, in particular, left ventricular noncompaction, requires a comprehensive clinical, segregation and bioinformatic analysis using international databases and the use of bioinformatics software.


  • FEATURES OF THE CLINICAL PHENOTYPE OF FILAMINE CARDIOMYOPATHIES WITH A DEBUT IN EARLY CHILDHOOD

    by T.L. Vershinina, Yu.V. Fomicheva, E.S. Vasichkina, A.S. Muravyov, A.I. Churkina, O.V. Melnik, A.M. Kiselev, T.M. Pervunina, A.A. Kostareva

    Облако Mail.ru - это ваше персональное надежное хранилище в интернете.


  • Open Access

    Damages of Cardiovascular System at Mucopolysaccharidosis Type I: Clinical Cases

    by Elena S. Vasichkina, Tatyana L. Vershinina, Tatyana S. Kovalchuk, Ekaterina N. Blinova, Elizaveta V. Malkina, Tatyana M. Pervunina

    Поражение сердечно-сосудистой системы при мукополисахаридозе I типа: клинические случаи


  • Open Access

    Variants of RBM20 gene in pediatric patients with dilated cardiomyopathy

    by A. M. Kiselev, T. L. Vershinina, S. I. Tarnovskaya, E. V. Yakovleva, L. Butish, Yu. V. Fomicheva, P. A. Fedotov, A. A. Kozyreva, Yu. A. Vakhrushev, A. K. Latypov, et al.

    Варианты в гене RBM20 у пациентов детского возраста с дилатационной кардиомиопатией


  • Open Access

    BARTH SYNDROME IN PRACTICE OF CARDIOLOGY

    by О. В. Мельник, T. S. Loevets, T. L. Vershinina, A. Ya. Gudkova, Yu. V. Fomicheva, A. A. Kostareva, T. M. Pervunina, Елена Сергеевна Васичкина

    СИНДРОМ БАРТА В ПРАКТИКЕ КАРДИОЛОГА